Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma
The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
The 10 Best La Roche-Posay Products for Every Skin Concern, Tested by Editors
Skin care aficionados everywhere are making space for a dermatologist-backed, budget-friendly brand in their medicine ...
Spark Therapeutics, a Philly biotech pioneer, is being restructured amid financial write-downs
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
Fierce Pharma11d
Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
STAT2d
Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
the current widely prescribed type of medicine aimed at obesity and diabetes. Roche has been making the case that the obesity market is large enough for it to enter the field, if a bit later than ...
pharmaphorum6y
Roche to buy rest of genetics firm Foundation Medicine
Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion. The Swiss pharma giant already bought 56% of FMI in 2015 for $1 billion ...